ORTEXORTEX News
Tracking CBL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CB
Earnings PreviewCBL

CBL Heads Into Earnings With Insider Selling and a 43% Short Interest Spike

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 7 Aug 2026, 04:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CBL & Associates Properties reports today against a backdrop that has grown notably more complicated over the past month — a sharp rise in bearish positioning, a wave of insider selling, and a stock that has pulled back sharply from recent highs.

The most striking development heading into the print is in short interest, which has climbed 43% over the past month to reach 3.2% of the free float. That build is meaningful for a small-float REIT. The jump appears to have begun around July 10, when shares short leapt from roughly 688,000 to around 956,000 in a single session — a step-change that has held ever since. Despite that, the lending market remains extremely loose: availability runs at over 7,100% of shares borrowed, meaning there are roughly 71 shares available to borrow for every one already out. Borrowing costs are modest at under 1%. Shorts face no squeeze pressure whatsoever from the borrow market.

Price action reinforces the cautious mood. CBL has shed 6.8% over the past week and 4.2% in Thursday's session alone, dropping to $54.31. That follows a strong month overall — up 2.7% — suggesting the recent pullback is concentrated and sharp. Peers have also slipped, but by less: MAC fell 2.7% on the week, SPG 4.6%, and KIM 4.4%, meaning CBL is underperforming even a weak sector tape. Options positioning has actually shifted less bearish than usual into the print: the put/call ratio sits at 2.85, nearly 1.7 standard deviations below its 20-day average of 3.32 — a rare signal that options traders are running with fewer puts relative to recent norms, even as the stock sells off.

The insider data adds a notable layer. Over the past 90 days, insiders have net sold roughly 1.07 million shares worth nearly $50 million. The most significant single transaction was Canyon Capital Advisors — the largest shareholder with a nearly 24% stake — trimming 1.05 million shares at around $46.44 in late May, worth $48.8 million. Since then, the CFO and several senior vice presidents have also sold smaller tranches in June, all at prices between $47.92 and $48.57. With the stock now trading at $54.31, those sales look well-timed. Canyon remains the dominant holder at just under 24%, and its next move — further reduction or stabilisation — is a structural question for the stock's float dynamics.

On the analyst side, coverage is thin and skewed to a single voice. Ladenburg Thalmann has raised its target twice in 2026 — from $50 to $52 in May and to $55 in June — while maintaining a Buy. The current mean target of $60 implies roughly 10% upside from Thursday's close, but with one firm effectively setting the consensus, that target carries limited weight as a market-wide read. The data is flagged as stale by ORTEX standards at 37 days old. There is no material bear case from the analyst community — the short thesis appears to live in positioning rather than published research.

The earnings report this afternoon will test whether the month-long short-interest build and insider selling reflect genuine concern about CBL's operational trajectory, or simply disciplined profit-taking after a stock that was up nearly 60% year-to-date as recently as early August.

Stocks in this article

See the live data behind this article on ORTEX.

Open CBL on ORTEX →

How this article was generated

Generated
7 Aug 2026, 04:28
Data as of
7 Aug 2026, 04:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.